104 related articles for article (PubMed ID: 9973255)
1. The Adrenomedullin gene is a target for negative regulation by the Myc transcription complex.
Wang X; Peters MA; Utama FE; Wang Y; Taparowsky EJ
Mol Endocrinol; 1999 Feb; 13(2):254-67. PubMed ID: 9973255
[TBL] [Abstract][Full Text] [Related]
2. Regulation of adrenomedullin gene transcription and degradation by the c-myc gene.
Ozawa N; Shichiri M; Fukai N; Yoshimoto T; Hirata Y
Endocrinology; 2004 Sep; 145(9):4244-50. PubMed ID: 15192039
[TBL] [Abstract][Full Text] [Related]
3. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
4. Induction of max by adrenomedullin and calcitonin gene-related peptide antagonizes endothelial apoptosis.
Shichiri M; Kato H; Doi M; Marumo F; Hirata Y
Mol Endocrinol; 1999 Aug; 13(8):1353-63. PubMed ID: 10446908
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia regulates the expression of the adrenomedullin and HIF-1 genes in cultured HL-1 cardiomyocytes.
Nguyen SV; Claycomb WC
Biochem Biophys Res Commun; 1999 Nov; 265(2):382-6. PubMed ID: 10558876
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of human adrenomedullin gene in vascular endothelial cells.
Ishimitsu T; Miyata A; Matsuoka H; Kangawa K
Biochem Biophys Res Commun; 1998 Feb; 243(2):463-70. PubMed ID: 9480831
[TBL] [Abstract][Full Text] [Related]
7. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and functional analysis of the promoter region of rat nonmuscle myosin heavy chain-B gene.
Yam JW; Chan KW; Li N; Hsiao WL
Biochem Biophys Res Commun; 2000 Oct; 276(3):1203-9. PubMed ID: 11027611
[TBL] [Abstract][Full Text] [Related]
9. v-Myc, but not Max, possesses domains that function in both transcription activation and cellular transformation.
Min S; Taparowsky EJ
Oncogene; 1992 Aug; 7(8):1531-40. PubMed ID: 1630816
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of the carboxy-terminal transforming region of v-Myc: binding to Max is necessary, but not sufficient, for cellular transformation.
Min S; Mascarenhas NT; Taparowsky EJ
Oncogene; 1993 Oct; 8(10):2691-701. PubMed ID: 8378081
[TBL] [Abstract][Full Text] [Related]
11. Basal levels of max are sufficient for the cotransformation of C3H10T1/2 cells by ras and myc.
Davenport EA; Taparowsky EJ
Exp Cell Res; 1992 Oct; 202(2):532-40. PubMed ID: 1397104
[TBL] [Abstract][Full Text] [Related]
12. Cooperation of oncogenes in the multistep transformation of established fibroblasts in culture.
Davenport EA; Drobes BL; Menke SL; Vaidya TB; Taparowsky EJ
Anticancer Res; 1988; 8(5A):959-69. PubMed ID: 2845855
[TBL] [Abstract][Full Text] [Related]
13. Identification of adipocyte differentiation-related regulatory element for adrenomedullin gene repression (ADRE-AR) in 3T3-L1 cells.
Li Y; Zhang Y; Furuyama K; Yokoyama S; Takeda K; Shibahara S; Takahashi K
Peptides; 2006 Jun; 27(6):1405-14. PubMed ID: 16376459
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis.
Garayoa M; Martínez A; Lee S; Pío R; An WG; Neckers L; Trepel J; Montuenga LM; Ryan H; Johnson R; Gassmann M; Cuttitta F
Mol Endocrinol; 2000 Jun; 14(6):848-62. PubMed ID: 10847587
[TBL] [Abstract][Full Text] [Related]
15. Identification of secondary structure in the 5'-untranslated region of the human adrenomedullin mRNA with implications for the regulation of mRNA translation.
Brenet F; Dussault N; Delfino C; Boudouresque F; Chinot O; Martin PM; Ouafik LH
Oncogene; 2006 Oct; 25(49):6510-9. PubMed ID: 16715138
[TBL] [Abstract][Full Text] [Related]
16. Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells.
Stewart MJ; Litz-Jackson S; Burgess GS; Williamson EA; Leibowitz DS; Boswell HS
Leukemia; 1995 Sep; 9(9):1499-507. PubMed ID: 7658719
[TBL] [Abstract][Full Text] [Related]
17. The transcription activation domains of v-Myc and VP16 interact with common factors required for cellular transformation and proliferation.
Min S; Crider-Miller SJ; Taparowsky EJ
Cell Growth Differ; 1994 Jun; 5(6):563-73. PubMed ID: 8086335
[TBL] [Abstract][Full Text] [Related]
18. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
19. Repression of cyclin D1: a novel function of MYC.
Philipp A; Schneider A; Väsrik I; Finke K; Xiong Y; Beach D; Alitalo K; Eilers M
Mol Cell Biol; 1994 Jun; 14(6):4032-43. PubMed ID: 8196642
[TBL] [Abstract][Full Text] [Related]
20. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
